Literature DB >> 33713682

Coronavirus disease 2019 impact on abortion care at a Northern California tertiary family planning program.

Mitchell D Creinin1, Hailee Tougas2, Machelle Wilson3, Melissa C Matulich4.   

Abstract

Entities:  

Year:  2021        PMID: 33713682      PMCID: PMC7944880          DOI: 10.1016/j.ajog.2021.03.007

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.

Objective

This study aimed to assess surgical abortion procedures at a Northern California tertiary referral center during the early outbreak (February 2020), the initial surge (March to April 2020), and decline (May 2020) of the coronavirus disease 2019 (COVID-19) pandemic.

Study Design

We accessed a deidentified database that contained patient referral information to extract data by month for February to May in the years 2017 to 2020. We evaluated referring provider or self-referral, procedure indication, gestational age on the procedure day, and COVID test results, when available. We used R (R Core Team, 2020, Vienna, Austria) to calculate Poisson prediction intervals for each month, based on values from 2017 to 2019, to assess whether the monthly 2020 values were significantly different from expected (ie, outside the 95% prediction interval) based on source, referral indication, and gestational age (at 15- and 20-week cutoffs). No institutional abortion access- or provision-related changes occurred during the years evaluated. Our institution did not suggest routine COVID-19 testing for preoperative patients until April 2, 2020, and required testing as of April 13, 2020. The University of California, Davis Institutional Review Board determined this evaluation as exempt.

Results

For the months of February to May, our service received 355, 434, 507, and 555 surgical abortion referrals in the years 2017, 2018, 2019, and 2020, respectively. During these years, we performed 163 (46% of referrals), 203 (47%), 169 (33%), and 235 procedures (42%). The number of referrals and procedures performed fluctuated from month to month and year to year, with an increase in referrals in February and March 2020 compared with previous years, correlating with an increase in the number of procedures in March and April 2020 of 35% to 52% compared with the previous 3 years (Table ). Based on Poisson prediction intervals, the number of procedures in February and May was within the expected range, but March and April represented a significant increase. Most of the procedures we performed were referred from community clinics, and these clinics accounted primarily for the increase in the number of procedures. We identified no significant increase in procedures for any month of 2020 compared with previous years based on referral source. We identified significant increases in March by indication (patient choice only [40 vs mean 25 for 2017–2019] and not for pregnancy loss or anomaly). Procedure volume increased significantly in gestations of 15 weeks or more in March and April 2020 (mean 60 in 2017–2019 vs 97 in 2020; 61% increase), mainly from procedures at 20 weeks or more (mean 26 compared with 63, respectively; 145% increase). Of 105 patients (all in April and May) who had COVID-19 testing, none had a positive result.
Table

Surgical abortion referrals and procedures in February to May 2020 compared with previous years at a Northern California tertiary referral center

2017201820192020Poisson prediction intervals
Mean (2017–2019)Variance (2017–2019)Boundsa
Surgical referrals
 February68118117163101.0187.079, 125
 March93100111157101.382.379, 126
 April83110137124110.0729.087, 135
 May111106142111119.67380.365, 146
 Total355434507555
Surgical procedures
 February3949405142.730.328, 59
 March4649396244.726.330, 61
 April3949496545.733.331, 63
 May3956415745.386.330, 62
 Total163203169235
Procedures as percentage of referrals45.9%46.8%33.3%42.3%

Creinin. Coronavirus disease 2019 impact on abortion care at a Northern California. Am J Obstet Gynecol 2021.

A value in 2020 outside the bounds indicates statistical significance (unexpected value).

Surgical abortion referrals and procedures in February to May 2020 compared with previous years at a Northern California tertiary referral center Creinin. Coronavirus disease 2019 impact on abortion care at a Northern California. Am J Obstet Gynecol 2021. A value in 2020 outside the bounds indicates statistical significance (unexpected value).

Conclusion

During the initial COVID-19 surge, our Northern California tertiary reproductive health referral center experienced a significant increase in abortion referrals in February and March 2020, correlating with a significant overall increase in procedures during March and April 2020, the initial peak months of COVID-19 cases in the United States. These data come from a region with relatively low COVID-19 infection rates during the months analyzed; it is possible that service availability in areas with higher infection burden was affected differently. The increase in referrals and procedures during the initial surge of this pandemic may just be an extreme of the normal variations we experience from month to month and year to year; we will not be able to discern this limitation until we have data for another 1 to 2 years. At a minimum, for now, we can conclude that the need for tertiary-level abortion care does not decline during the pandemic. Legislation aimed at restricting abortion access during the pandemic are contrary to patient need.
  2 in total

1.  Impact of COVID-19 on abortion method under ten weeks gestational age in Southern California.

Authors:  Renee T Sullender; Marni Jacobs; Kyle Bukowski; Antoinette Marengo; Sheila K Mody; Sarah H Averbach
Journal:  Contraception       Date:  2022-03-06       Impact factor: 3.051

2.  Impact of the COVID-19 pandemic on access to and utilisation of services for sexual and reproductive health: a scoping review.

Authors:  Hannah VanBenschoten; Hamsadvani Kuganantham; Elin C Larsson; Margit Endler; Anna Thorson; Kristina Gemzell-Danielsson; Claudia Hanson; Bela Ganatra; Moazzam Ali; Amanda Cleeve
Journal:  BMJ Glob Health       Date:  2022-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.